1,3-Di-tert-butylimidazol-2-ylidene / 1 g
Safety Information
Hazard Statements
Precautionary Statements
Pictograms
Properties
Signal Word | Danger |
Product Description
1,3-Di-tert-butylimidazol-2-ylidene is a substituted imidazol-2-ylidene bearing two tert-butyl groups. Imidazol-2-ylidenes are part of a broader class of compounds known as N-heterocyclic carbenes (NHCs), which are recognized for their ability to form strong bonds with metals, making them valuable ligands in organometallic chemistry. The presence of bulky tert-butyl groups enhances the steric hindrance around the carbene carbon, influencing its reactivity and stability. These features position 1,3-Di-tert-butylimidazol-2-ylidene as a potentially useful building block in the synthesis of complexes with tailored electronic and steric properties.
Application
In practical applications, 1,3-Di-tert-butylimidazol-2-ylidene could be utilized as a ligand in the preparation of metal complexes for catalysis, particularly in homogeneous catalysis where its NHC backbone can stabilize reactive metal centers. Its sterically demanding substituents may also influence the selectivity of catalyzed reactions, making it of interest in the development of new catalysts for challenging transformations. Additionally, its basicity and nucleophilicity suggest potential applications in organic synthesis, where it could serve as a directing group or activating agent in reaction sequences.
Articles:
- Basicity of a Stable Carbene, 1,3-Di-tert-butylimidazol-2-ylidene, in THF
Publication Date: April 25, 2002
Yeong-Joon Kim and Andrew Streitwieser
https://doi.org/10.1021/ja025628j
- Preparation of Monomeric [LAl(NH2)2]—A Main-Group Metal Diamide Containing Two Terminal NH2 Groups
Publication Date: 06 April 2004
Vojtech Jancik Dipl.-Chem., Leslie W. Pineda Dipl.-Chem., Jiri Pinkas Prof. Dr., Herbert W. Roesky Prof. Dr., Dante Neculai Dr., Ana M. Neculai Dr., Regine Herbst-Irmer Dr.
https://doi.org/10.1002/anie.200353541
- Ruthenium Hydride Complexes of 1,2-Dicyclohexylimidazol-2-ylidene
Publication Date: October 21, 2005
Suzanne Burling, Gabriele Kociok-Köhn, Mary F. Mahon, Michael K. Whittlesey, and Jonathan M. J. Williams